The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2025 / November / The Shift to Agile, Modular Manufacturing
Cell & Gene Biopharma Facilities & Equipment Bioprocessing Sponsored

The Shift to Agile, Modular Manufacturing

As industry conversations around manufacturing change, we caught up with Cytiva’s Joe Makowiecki to discuss modular and flexible solutions.

11/28/2025 0 min read Video

Sponsored By

Cytiva

Share

Take a look at the KUBio box trailer with Cytiva’s FlexFactory manufacturing solution that was on display at CPHI Frankfurt 2025!

“The shift towards personalized and advanced therapies, such as MRNA, viral vectors, and cell and gene therapies, has really redefined biomanufacturing, moving away from centralized large-scale facilities towards more agile, more modular environments,” says Joe Makowiecki, Enterprise Solutions Director of Product Management & Engineering at Cytiva.

Learn more about flexible manufacturing and Cytiva’s end-to-end offering in this video interview with Makowiecki.

He adds: “Cytiva delivers comprehensive support across the entire biomanufacturing lifecycle, from facility design and process development to equipment integration, automation, operator training and ongoing service. This holistic approach allows customers to focus on science; focus on their product pipeline and operations while Cytiva manages the infrastructure and complexity required to efficiently and compliantly bring manufacturing capacity online.”

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

The Hidden Complexity of Stability Storage
Biopharma Technology & Manufacturing
The Hidden Complexity of Stability Storage

August 27, 2026

9 min read

Why preserving samples is a scientific, regulatory, and operational challenge – and what’s at risk when it goes wrong

Green Shoots, Gray Skies
Biopharma Interviews Business & Trends
Green Shoots, Gray Skies

August 26, 2026

9 min read

Jon Rees sees signs of recovery following biotech's post-pandemic funding reset, but there’s no going back to the “old normal”

Phase III Success Marks Milestone for Personalized Cancer Vaccines
Biopharma Industry News Development & Clinical
Phase III Success Marks Milestone for Personalized Cancer Vaccines

August 26, 2026

7 min read

Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field

The Mindset for Success in Biopharma's New Multipolar World
Biopharma Development & Clinical Outsourcing
The Mindset for Success in Biopharma's New Multipolar World

August 18, 2026

10 min read

From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: